Effectiveness of Self-Help for Dually-Diagnosed Persons - 1
This study has been completed.
Sponsor:
Collaborator:
National Development and Research Institutes, Inc.
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00218582
First received: September 20, 2005
Last updated: October 27, 2008
Last verified: October 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.
| Condition | Intervention | Phase |
|---|---|---|
|
Dual Diagnosis Substance-Related Disorders Mental Disorders |
Behavioral: Double Trouble in Recovery Behavioral: Standard psychiatric day treatment |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effectiveness of Self-Help for Dually-Diagnosed Persons |
Resource links provided by NLM:
Further study details as provided by National Institute on Drug Abuse (NIDA):
Primary Outcome Measures:
- drug/alcohol use [ Time Frame: past 90 days ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- psychiatric medication adherence [ Time Frame: recent ] [ Designated as safety issue: No ]
- traditional 12 step meeting attendance [ Time Frame: past 90 days ] [ Designated as safety issue: No ]
- psychiatric symptoms [ Time Frame: recent ] [ Designated as safety issue: No ]
- program retention [ Time Frame: up to 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 229 |
| Study Start Date: | March 2003 |
| Study Completion Date: | March 2007 |
| Primary Completion Date: | March 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
|
Behavioral: Double Trouble in Recovery
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
|
|
Active Comparator: 2
Standard psychiatric day treatment
|
Behavioral: Standard psychiatric day treatment
Individual counseling, groups, medication
|
Eligibility| Ages Eligible for Study: | 18 Years to 64 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
Admission to psychiatric day treatment program 18-64 years old
Exclusion Criteria:
Did not understand or speak English, appeared intoxicated on drugs or alcohol, carried a diagnosis of mental retardation, were deemed actively psychotic by the clinic's intake coordinator, appeared unable to understand and give informed consent.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00218582
Locations
| United States, New York | |
| Albert Einstein Dept of Psychiatry | |
| Bronx, New York, United States, 10461 | |
Sponsors and Collaborators
National Development and Research Institutes, Inc.
Investigators
| Principal Investigator: | Stephen Magura, Ph.D. | National Development and Research Institutes, Inc. |
More Information
Publications:
| Responsible Party: | Stephen Magura, Western Michigan University |
| ClinicalTrials.gov Identifier: | NCT00218582 History of Changes |
| Other Study ID Numbers: | NIDA-15912-1, R01-15912-1 |
| Study First Received: | September 20, 2005 |
| Last Updated: | October 27, 2008 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute on Drug Abuse (NIDA):
|
12 step groups self help psychiatric day treatment co-occurring disorders dual diagnosis |
Additional relevant MeSH terms:
|
Mental Disorders Psychotic Disorders Substance-Related Disorders Schizophrenia and Disorders with Psychotic Features |
ClinicalTrials.gov processed this record on June 18, 2013